Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2018 3
2021 2
2022 3
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Antimetastatic defense by CD8+ T cells.
Tallón de Lara P, Castañón H, Sterpi M, van den Broek M. Tallón de Lara P, et al. Trends Cancer. 2022 Feb;8(2):145-157. doi: 10.1016/j.trecan.2021.10.006. Epub 2021 Nov 21. Trends Cancer. 2022. PMID: 34815204 Review.
Primary Pulmonary NUT Carcinoma: Case Illustration and Updated Review of Literature.
Costa BA, Maraveyas A, Wilkoff MH, Correia GSC, Tallón de Lara P, Rohs NC, Salonia J. Costa BA, et al. Among authors: tallon de lara p. Clin Lung Cancer. 2022 Jun;23(4):e296-e300. doi: 10.1016/j.cllc.2022.03.001. Epub 2022 Mar 17. Clin Lung Cancer. 2022. PMID: 35400585 Review. No abstract available.
CD39+PD-1+CD8+ T cells mediate metastatic dormancy in breast cancer.
Tallón de Lara P, Castañón H, Vermeer M, Núñez N, Silina K, Sobottka B, Urdinez J, Cecconi V, Yagita H, Movahedian Attar F, Hiltbrunner S, Glarner I, Moch H, Tugues S, Becher B, van den Broek M. Tallón de Lara P, et al. Nat Commun. 2021 Feb 3;12(1):769. doi: 10.1038/s41467-021-21045-2. Nat Commun. 2021. PMID: 33536445 Free PMC article.
CSF1R-dependent myeloid cells are required for NK‑mediated control of metastasis.
Beffinger M, Tallón de Lara P, Tugues S, Vermeer M, Montagnolo Y, Ohs I, Cecconi V, Lucchiari G, Gagliardi A, Misljencevic N, Sutton J, Spörri R, Becher B, Gupta A, van den Broek M. Beffinger M, et al. Among authors: tallon de lara p. JCI Insight. 2018 May 17;3(10):e97792. doi: 10.1172/jci.insight.97792. eCollection 2018 May 17. JCI Insight. 2018. PMID: 29769439 Free PMC article.
Does telaprevir possess a direct antidiabetic effect?
Tallón de Lara P, Himschoot T, Frossard JL, Negro F. Tallón de Lara P, et al. Liver Int. 2014 Jul;34(6):967-9. doi: 10.1111/liv.12440. Epub 2014 Jan 16. Liver Int. 2014. PMID: 24329983
Gemcitabine Synergizes with Immune Checkpoint Inhibitors and Overcomes Resistance in a Preclinical Model and Mesothelioma Patients.
Tallón de Lara P, Cecconi V, Hiltbrunner S, Yagita H, Friess M, Bode B, Opitz I, Vrugt B, Weder W, Stolzmann P, Felley-Bosco E, Stahel RA, Tischler V, Britschgi C, Soldini D, van den Broek M, Curioni-Fontecedro A. Tallón de Lara P, et al. Clin Cancer Res. 2018 Dec 15;24(24):6345-6354. doi: 10.1158/1078-0432.CCR-18-1231. Epub 2018 Aug 28. Clin Cancer Res. 2018. PMID: 30154226 Free article.
A novel evidence-based predictor tool for hospitalization and length of stay: insights from COVID-19 patients in New York city.
El Halabi M, Feghali J, Bahk J, Tallón de Lara P, Narasimhan B, Ho K, Sehmbhi M, Saabiye J, Huang J, Osorio G, Mathew J, Wisnivesky J, Steiger D. El Halabi M, et al. Among authors: tallon de lara p. Intern Emerg Med. 2022 Oct;17(7):1879-1889. doi: 10.1007/s11739-022-03014-9. Epub 2022 Jun 30. Intern Emerg Med. 2022. PMID: 35773370 Free PMC article.
Comparing Anticoagulation Strategies for Venous Thromboembolism Associated With Active Cancer: A Systematic Review and Meta-Analysis.
Fujisaki T, Sueta D, Yamamoto E, Buckley C, Sacchi de Camargo Correia G, Aronson J, Tallón de Lara P, Fujisue K, Usuku H, Matsushita K, Mehran R, Dangas GD, Tsujita K. Fujisaki T, et al. Among authors: tallon de lara p. JACC CardioOncol. 2024 Jan 9;6(1):99-113. doi: 10.1016/j.jaccao.2023.10.009. eCollection 2024 Feb. JACC CardioOncol. 2024. PMID: 38510285 Free PMC article.